• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>Eli Lilly

Eli Lilly

Eli Lilly and Co LLY

Last Price$81.51Day Change (%)-0.09%
Open Price$81.59Day Change ($)-0.08
Day Range81.00–81.7252-Week Range67.88–92.85

As of Mon 7/25/2016 2:50:00 PM | USD

  1. All
  2. Morningstar Articles
  3. Videos
  4. 3rd Party
  5. Investing
  1. Fitch Affirms Eli Lilly's IDR at 'A'; Outlook Stable

    Fitch Affirms Eli Lilly's IDR at 'A'; Outlook Stable

  2. Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Pipeline Review, H1 2016 Featuring AskAt, Eisai, Eli Lilly and Company, Kaken Pharmaceutical & Ono Pharmaceutical - Research ...

    Prostaglandin E2 Receptor EP4 Subtype (Prostanoid EP4 Receptor or PTGER4) Pipeline Review, H1 2016 Featuring AskAt, Eisai, Eli Lilly and Company, Kaken Pharmaceutical & Ono Pharmaceutical - Research and Markets

  3. Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

    Global Bladder Cancer Therapeutics & Diagnostics Market - Expected to Grow 3-5% by 2020 - Research and Markets

  4. Global Psoriasis Market Growth of 7.26% by 2024 - Analysis, Technologies & Forecasts Report 2016-2024 - Key Vendors: Johnson & Johnson, Novartis, Pfizer - Research and Markets

    Global Psoriasis Market Growth of 7.26% by 2024 - Analysis, Technologies & Forecasts Report 2016-2024 - Key Vendors: Johnson & Johnson, Novartis, Pfizer - Research and Markets

  5. Global Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) Pipeline Review 2016 - Research and Markets

    Global Metabotropic Glutamate Receptor 5 (mGluR5 or GRM5 or GPRC1E or MGLUR5) Pipeline Review 2016 - Research and Markets

  6. Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis, Bayer - Research and Markets

    Global Bile Duct Cancer (Cholangiocarcinoma) Clinical Trials Review, H1, 2016 - Analysis, Technologies & Forecasts Report - Key Vendors: Sanofi, Novartis, Bayer - Research and Markets

  7. PureTech Appoints Feng Zhang to Scientific Advisory Board and Expands Team and Advisory Group

    PureTech Appoints Feng Zhang to Scientific Advisory Board and Expands Team and Advisory Group

  8. Dendrimers and Polymer Drug Conjugates Market (2016 - 2026) - 40 Polymer Drug Conjugates in Clinical Development - Research and Markets

    Dendrimers and Polymer Drug Conjugates Market (2016 - 2026) - 40 Polymer Drug Conjugates in Clinical Development - Research and Markets

  9. Why Are Primecap Funds So Sustainable?

    These Gold-rated funds have Morningstar Sustainability Ratings of High despite not explicitly trying to do so.

  10. SEC, FINRA Enforcement Roundup: Eli Lilly to Pay $29M to Settle Foreign Bribery Charges

    The SEC recently charged Eli Lilly for violations of the FCPA and barred an Arizona-based fund manager from the industry after the fund’s collapse. FINRA ordered Pruco Securities to pay $10.7 million.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.